Latest Articles

A pilot study led by Professor Phillip Popovich has placed focus on how traumatic SCI might impact the gut microbiome – the population of microbes inhabiting the digestive tract. We spoke to study author Ahmed Zayed to find out more.

While industrial laboratories can screen vast numbers of potential drug compounds, many academic researchers are adopting more focused strategies.

We spoke to Tasnime Osama, honorary clinical research fellow at Imperial College London to learn about the ethical considerations surrounding vaccine passports and how ethical hacking could improve their security.

This article discusses the opportunity to use recent advancements in AI and machine learning for natural product drug discovery.

In this article, we will explore the manufacturing strategies and tools that the biopharmaceutical industry adopted to make such efficient COVID-19 vaccine production possible.

Part of what has enabled collaborations to emerge relatively smoothly over recent years, and especially the past year, has been a growing trend toward digital transformation. In this article, we explore how digital collaboration will pave the way to a new era of drug development.

When South Africa went into lockdown on March 26, 2020, due to COVID-19, the country’s computing needs vastly outgrew the resources provided by Lengau and the OpenStack Production Cloud. In this article, we explore how the South Africa Center for High Performance Computing responded.

A study investigated whether sunlight might affect COVID-19 mortality, using a study sample incorporating several different countries: The United States, Italy and England. The researchers found that sunnier areas are associated with fewer deaths from COVID-19. Technology Networks spoke with Dr Richard Weller to find out more.

The past few decades have witnessed a dramatic growth in the use of novel approaches and technologies in drug discovery. The availability of massive data sets and advanced algorithms has driven more interest and major improvements in the use of artificial intelligence (AI) in the field.

Liquid chromatography (LC) systems are the backbone of pharmaceutical and biopharmaceutical laboratories. However, with increasingly complex samples and efficiency pressures, scientists are seeking more confidence in their results. Can innovative two-dimensional LC (2D-LC) systems provide the answer?